VEGFA and colorectal cancer: Studies indicate that neutrophil infiltration can counteract anti-VEGF therapy (45), while the combination of immune checkpoint inhibitors and anti-angiogenic agents, such as regorafenib and nivolumab (46), shows promise in treating advanced colorectal cancer.